Evaluation of the use of low-dose quetiapine and the risk of metabolic consequences: A retrospective review

INTRODUCTION: Quetiapine fumarate is an atypical antipsychotic approved for the treatment of schizophrenia, major depressive disorder, and bipolar disorder. Due to the sedative effects observed at low doses, prescribers use quetiapine to aid patients with sleep disturbances. Current evidence has est...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ment Health Clin
Egile Nagusiak: Carr, Chelsea N., Lopchuk, Shruti, Beckman, Mary E., Baugh, Terrence Bradley
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: College of Psychiatric & Neurologic Pharmacists 2016
Gaiak:
Open Submissions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007538/
https://ncbi.nlm.nih.gov/pubmed/29955487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2016.11.308
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak